Ventricular tachycardia risk factors: Difference between revisions
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors for ventricular tachycardia include:<ref name="pmid38000753">{{cite journal |author=Baerman JM, Morady F, DiCarlo LA, de Buitleir M |title=Differentiation of ventricular tachycardia from supraventricular tachycardia with aberration: value of the clinical history |journal=[[Annals of Emergency Medicine]] |volume=16 |issue=1 |pages=40–3|pmid=3800075 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0196-0644(87)80283-4 |issn= |accessdate=2013-08-04}}</ref> | Common risk factors for ventricular tachycardia include:<ref name="pmid38000753">{{cite journal |author=Baerman JM, Morady F, DiCarlo LA, de Buitleir M |title=Differentiation of ventricular tachycardia from supraventricular tachycardia with aberration: value of the clinical history |journal=[[Annals of Emergency Medicine]] |volume=16 |issue=1 |pages=40–3|pmid=3800075 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0196-0644(87)80283-4 |issn= |accessdate=2013-08-04}}</ref> | ||
<br /> | |||
== | {| class="wikitable" | ||
|+ | |||
! colspan="2" |Risk Factors for Ventricular Tachycardia | |||
|- | |||
|Reversible Risk Factors | |||
| | |||
*[[Antiarrhythmics]] | *[[Antiarrhythmics]] | ||
*[[Amphetamines]] | *[[Amphetamines]] | ||
| Line 18: | Line 22: | ||
*[[Phenothiazines]] | *[[Phenothiazines]] | ||
*[[Sympathomimetic agents]] | *[[Sympathomimetic agents]] | ||
|- | |||
|Irreversible Risk Factors | |||
| | |||
*[[Arrhythmogenic right ventricular dysplasia]] | *[[Arrhythmogenic right ventricular dysplasia]] | ||
*[[Channelopathies]] | *[[Channelopathies]] | ||
| Line 30: | Line 34: | ||
*[[Systemic lupus erythematosus]] | *[[Systemic lupus erythematosus]] | ||
*[[Tetralogy of Fallot]] | *[[Tetralogy of Fallot]] | ||
|- | |||
|Risk Factors for SVT | |||
| | |||
*[[Alcohol]] | *[[Alcohol]] | ||
*[[Anemia]] | *[[Anemia]] | ||
| Line 51: | Line 55: | ||
*[[Theobromine]] | *[[Theobromine]] | ||
*[[Theophylline]] | *[[Theophylline]] | ||
|} | |||
==References== | ==References== | ||
Revision as of 14:43, 10 December 2019
|
Ventricular tachycardia Microchapters |
|
Differentiating Ventricular Tachycardia from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Ventricular tachycardia risk factors On the Web |
|
Risk calculators and risk factors for Ventricular tachycardia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Overview
Risk factors for the ventricular tachycardia as a cause of wide complex tachycardia include a history of prior myocardial infarction, a history of congestive heart failure, and a history of recent angina pectoris. These three historical features have positive predictive values for VT of > 95% in a small study, but sensitivities of 66%, 24%, and 24%, respectively. Wide complex tachycardia will be due to VT in 98% of cases if there's a history of structural heart disease. Only 7% of patients with SVT with aberrancy will have had a prior myocardial infarction (MI).
Risk Factors
Common risk factors for ventricular tachycardia include:[1]
| Risk Factors for Ventricular Tachycardia | |
|---|---|
| Reversible Risk Factors | |
| Irreversible Risk Factors | |
| Risk Factors for SVT | |
References
- ↑ Baerman JM, Morady F, DiCarlo LA, de Buitleir M. "Differentiation of ventricular tachycardia from supraventricular tachycardia with aberration: value of the clinical history". Annals of Emergency Medicine. 16 (1): 40–3. PMID 3800075. Retrieved 2013-08-04.